We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.

The EMBO journal | Dec 1, 2000

Members of the mitogen-activated protein kinase (MAPK) cascade such as extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 are implicated as important regulators of cardiomyocyte hypertrophic growth in culture. However, the role that individual MAPK pathways play in vivo has not been extensively evaluated. Here we generated nine transgenic mouse lines with cardiac-restricted expression of an activated MEK1 cDNA in the heart. MEK1 transgenic mice demonstrated concentric hypertrophy without signs of cardiomyopathy or lethality up to 12 months of age. MEK1 transgenic mice showed a dramatic increase in cardiac function, as measured by echocardiography and isolated working heart preparation, without signs of decompensation over time. MEK1 transgenic mice and MEK1 adenovirus-infected neonatal cardiomyocytes each demonstrated ERK1/2, but not p38 or JNK, activation. MEK1 transgenic mice and MEK1 adenovirus-infected cultured cardiomyocytes were also partially resistant to apoptotic stimuli. The results of the present study indicate that the MEK1-ERK1/2 signaling pathway stimulates a physiologic hypertrophy response associated with augmented cardiac function and partial resistance to apoptotsis.

Pubmed ID: 11101507 RIS Download

Mesh terms: Actinin | Adenoviridae | Age Factors | Animals | Animals, Newborn | Apoptosis | Body Weight | Cardiomegaly | Caspase 3 | Caspases | Cells, Cultured | DNA Fragmentation | DNA, Complementary | Echocardiography | Electrophoresis, Polyacrylamide Gel | Immunohistochemistry | In Situ Nick-End Labeling | Leucine | MAP Kinase Kinase 1 | MAP Kinase Signaling System | Mice | Mice, Transgenic | Mitogen-Activated Protein Kinase 1 | Mitogen-Activated Protein Kinase 3 | Mitogen-Activated Protein Kinase 8 | Mitogen-Activated Protein Kinase Kinases | Mitogen-Activated Protein Kinases | Myocardium | Organ Size | Plasmids | Protein-Serine-Threonine Kinases | RNA | Rats | Reperfusion Injury | Reverse Transcriptase Polymerase Chain Reaction | Signal Transduction

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, Id: HL52318
  • Agency: NHLBI NIH HHS, Id: P50 HL052318
  • Agency: NHLBI NIH HHS, Id: R01 HL062927
  • Agency: NHLBI NIH HHS, Id: T32 HL007752
  • Agency: NHLBI NIH HHS, Id: HL69562
  • Agency: NHLBI NIH HHS, Id: HL62927

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.